CCL11 and neurodegenerative disease: Regarding CCL11, considerable evidence exists on the role of this chemokine in the progression of neurodegenerative diseases (e.g., schizophrenia or dementia patients) [22, 48], but contradictory results have been reported in relation to MDD.